Cannvas MedTech (CSE:MTEC), a leading business technology company within the cannabis space, is pleased to announce its listing on the Frankfurt Stock Exchange under the trading symbol “3CM”. The Frankfurt Exchange is a major international stock exchange and ranks third in terms of global volume of trading behind the New York and NASDAQ stock exchanges. The listing on the Frankfurt Stock Exchange provides Cannvas with broader access to European and other international investors.
“Our mandate is to continue to build exceptional shareholder value and the listing on the Frankfurt Stock Exchange gains us valuable access to the European and broader global investment market,” said Shawn Moniz, Chief Executive Officer, Cannvas. “The listing is another significant milestone for our young company as we look to expand our technological influence to Germany and Europe and around the globe. We invite all new investors to learn more about our company and about Cannvas.me, a scalable and comprehensive solution for the global cannabis community offering interactive tools and physician-backed content to all audiences who wish to learn about healthcare through cannabis.”
The Frankfurt Stock Exchange has more than 250 international trading institutions and more than 4,500 traders. The Frankfurt Stock Exchange accounts for over 90% of the volume of all German stock exchanges and represents a large share of the European market. Investors directly connected to the Frankfurt Stock Exchange represent 35% of the world’s investment capital. A listing in Frankfurt also provides a tax advantage to German investors.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company within the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
For additional information:
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.
For further information: Media Inquiries: firstname.lastname@example.org; Investor Relations: email@example.com, 1-800-489-0116
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/